Literature DB >> 19709097

Uncomplicated peptic ulcer in the UK: trends from 1997 to 2005.

S Cai1, L A García Rodríguez, E L Massó-González, S Hernández-Díaz.   

Abstract

BACKGROUND: Few studies have examined the incidence of uncomplicated peptic ulcer or the trends in factors affecting its incidence. AIM: To estimate the incidence rate of uncomplicated peptic ulcer in the UK from 1997 to 2005 and report temporal changes in the main known preventive and risk factors.
METHODS: Population-based cohort study of 1 049 689 patients enrolled in The Health Improvement Network in the UK. We estimated the incidence rate of uncomplicated peptic ulcer and evaluated temporal trends in demographic characteristics and prescription patterns for various anti-inflammatory and gastroprotective agents.
RESULTS: Overall uncomplicated peptic ulcer incidence was 0.75 cases per 1000 persons-years, declining from 1.1 to 0.52 cases per 1000 person-years between 1997 and 2005. Distributions of age, gender and alcohol habits were similar in 1997 and 2005. The proportion of documented Helicobacter pylori-negative cases increased from 5% to 12%. Monthly prevalence of subjects with prescriptions for traditional non-aspirin NSAIDs changed from 7.7% to 6.8%, Coxibs from 0% to 0.7%, and proton pump inhibitors (PPIs) from 2.4% to 7.4%. The proportion of subjects on prescription NSAIDs on PPIs increased continuously over time.
CONCLUSION: A reduction in H. pylori-related peptic ulcers, changing patterns in NSAID use and increasing PPI use may have contributed to a decline in uncomplicated peptic ulcer incidence in the UK.

Entities:  

Mesh:

Year:  2009        PMID: 19709097     DOI: 10.1111/j.1365-2036.2009.04131.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  12 in total

1.  The Novel Scoring System for 30-Day Mortality in Patients with Non-variceal Upper Gastrointestinal Bleeding.

Authors:  Sejin Hwang; Seong Woo Jeon; Joong Goo Kwon; Dong Wook Lee; Chang Yoon Ha; Kwang Bum Cho; ByungIk Jang; Jung Bae Park; Youn Sun Park
Journal:  Dig Dis Sci       Date:  2016-02-26       Impact factor: 3.199

2.  Aggressive Helicobacter pylori-negative peptic ulceration as the initial manifestation of Crohn's disease.

Authors:  James Callaghan; Sarah Brown; Tim Battcock; Sally Parry; Jonathon Snook
Journal:  Frontline Gastroenterol       Date:  2012-05-01

Review 3.  Prophylactic use of aspirin: systematic review of harms and approaches to mitigation in the general population.

Authors:  Mangesh A Thorat; Jack Cuzick
Journal:  Eur J Epidemiol       Date:  2014-11-25       Impact factor: 8.082

4.  When Should Antiplatelet Agents Be Resumed After Successful Endoscopic Hemostasis in Patients with Peptic Ulcer Bleeding?

Authors:  Jung-Wook Kim; Hyun Jin Park; Jae-Young Jang; Chi Hyuk Oh; Jae-Jun Shim; Chang Kyun Lee; Young Woon Chang
Journal:  Dig Dis Sci       Date:  2016-02-05       Impact factor: 3.199

Review 5.  The role of nitric oxide in peptic ulcer: a narrative review.

Authors:  Tian-Yu Liang; Ru-Ming Deng; Xiang Li; Xiang Xu; Gang Chen
Journal:  Med Gas Res       Date:  2021 Jan-Mar

6.  Assessment of some Herbal Drugs for Prophylaxis of Peptic Ulcer.

Authors:  Ahmed A Gohar; Ahmed A Zaki
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

7.  The Use of a Bayesian Hierarchy to Develop and Validate a Co-Morbidity Score to Predict Mortality for Linked Primary and Secondary Care Data from the NHS in England.

Authors:  Colin J Crooks; Tim R Card; Joe West
Journal:  PLoS One       Date:  2016-10-27       Impact factor: 3.240

8.  Risk factors associated with uncomplicated peptic ulcer and changes in medication use after diagnosis.

Authors:  Antonio González-Pérez; María E Sáez; Saga Johansson; Péter Nagy; Luis A García Rodríguez
Journal:  PLoS One       Date:  2014-07-08       Impact factor: 3.240

9.  Risk of uncomplicated peptic ulcer disease in a cohort of new users of low-dose acetylsalicylic acid for secondary prevention of cardiovascular events.

Authors:  Ana Ruigómez; Saga Johansson; Péter Nagy; Mar Martín-Pérez; Luis A García Rodríguez
Journal:  BMC Gastroenterol       Date:  2014-12-10       Impact factor: 3.067

Review 10.  Estimates of benefits and harms of prophylactic use of aspirin in the general population.

Authors:  J Cuzick; M A Thorat; C Bosetti; P H Brown; J Burn; N R Cook; L G Ford; E J Jacobs; J A Jankowski; C La Vecchia; M Law; F Meyskens; P M Rothwell; H J Senn; A Umar
Journal:  Ann Oncol       Date:  2014-08-05       Impact factor: 32.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.